The use of mycolactone, a small molecule that inhibits Sec61, along with PI was found to be effective in inducing apoptosis and synergistic in pre-clinical models of laboratory-derived MM cell lines [291]. The gene discussed is SEC61A1; the disease is Miyoshi myopathy.